$35 Billion Micro EVs, e-Bikes, e-Scooters, e-Motorbikes, Mobility Market for the Disabled 2017-2027
Jan 02, 2018 13:38 pm UTC| Business
Dublin, Jan. 02, 2018 -- The "Micro EVs, e-Bikes, e-Scooters, e-Motorbikes, Mobility for Disabled 2017-2027" report has been added to Research and Markets' offering. Small manned electric vehicles -...
GasLog Ltd. Places a Newbuilding Order at Samsung Heavy Industries
Jan 02, 2018 13:31 pm UTC| Business
Monaco - January 2, 2018 - GasLog Ltd. ("GasLog", NYSE: GLOG), an international owner, operator and manager of liquefied natural gas ("LNG") carriers, today announces that it has ordered a newbuild 180,000 cubic meter...
USEI Declares Warrant Dividend on Its Common Stock as Part of Its Cannabis Operations and Future
Jan 02, 2018 13:31 pm UTC| Business
SANTA CLARITA, CA, Jan. 02, 2018 -- USEI CANNABIS INITIATIVES CORP, a wholly owned subsidiary of U.S. ENERGY INITIATIVES CORPORATION, INC. (OTC PINK: USEI) a California based company, poised to capitalize on...
BriaCell To Attend Biotech Showcase™ 2018
Jan 02, 2018 13:30 pm UTC| Business
BERKELEY, Calif. and VANCOUVER, British Columbia, Jan. 02, 2018 -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted...
Finjan and FireEye Enter Patent License Agreements
Jan 02, 2018 13:30 pm UTC| Business
EAST PALO ALTO, Calif. and MILPITAS, Calif., Jan. 02, 2018 -- Finjan Holdings, Inc. (Nasdaq:FNJN) and FireEye, Inc. (NASDAQ:FEYE) today announced they entered into Confidential Patent License Agreements on December 29,...
Sarepta Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Jan 02, 2018 13:30 pm UTC| Business
CAMBRIDGE, Mass., Jan. 02, 2018 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare...
Jan 02, 2018 13:30 pm UTC| Business
SEATTLE, Jan. 02, 2018 -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that it received a product-specific pediatric waiver from the European Medicines Agency...